Work

Biomarkers Predictive of Survival and Response to Immune Checkpoint Inhibitors in Melanoma

Year: 2019

Type: article

Source: American Journal of Clinical Dermatology

DOI: 10.1007/s40257-019-00475-1

Authors: Emanuelle M. Rizk, Angelina M. Seffens, Megan H. Trager, Michael R. Moore, Larisa J. Geskin, Robyn D. Gartrell-Corrado, Winston Wong, Yvonne M. Saenger

Institutions: Columbia University Irving Medical Center, Columbia University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Howard Hughes Medical Institute, Melanoma Research Alliance, Swim Across America, National Institutes of Health, U.S. Food and Drug Administration, Irving Medical Center, Columbia University, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: G1133076894, G235420648, G3907338839, G48787781, G7686321745, A prognostic mRNA immune signature for resected stage II-III melanoma, G9000196512

OpenAlex ID: W2979474139

FWCI: 0.816

Cites: 134

Cited by: 20

Related to: 10